Evidence map›Paper›PMID 40187742›Full record

Observational studyEuropean journal of public health2025

Sexually transmitted infections among pre-exposure prophylaxis users in a Swedish multi-centre cohort.

Tobias Herder, Fredrik Månsson, Petra Tunbäck, Karin Sanner, Magnus Gisslén, Ester Fridenström, Minna Dawar, Susanne Strömdahl

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in European journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tobias HerderSocial Medicine & Global Health, Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden.ORCID 0000-0002-8504-4031
Fredrik MånssonClinical Infection Medicine, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.ORCID 0000-0002-2802-0420
Petra TunbäckDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0001-8423-8566
Karin SannerDepartment of Dermatology and Venereology, Uppsala University Hospital, Region Uppsala, Sweden.ORCID 0009-0007-7588-6407
Magnus GisslénDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-2357-1020
Ester FridenströmInfection Medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Minna DawarClinical Infection Medicine, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.ORCID 0009-0007-0146-392X
Susanne StrömdahlInfection Medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-6706-0177

Funding

ALF ALFGBG-965885Public Health Agency of SwedenUppsala University Hospital
6 · The paper itself

Abstract

An additional upsurge in bacterial STIs has been observed in Sweden following HIV pre-exposure prophylaxis (PrEP) implementation. From a prevention perspective, it is of relevance to optimize testing strategies within PrEP programmes to identify those most at risk. An open retrospective longitudinal observational cohort study was performed at three STI clinics in Uppsala, Gothenburg, and Malmö. A questionnaire and journal data regarding STI were collected from a sample of 199 MSM enrolled in the PrEP programmes and providing informed consent. Incident bacterial STIs during follow-up were analyzed with descriptive statistics, Poisson regression, and Cox regression. Median follow-up time was 632 days. A total of 270 gonorrhoea or chlamydia infections were recorded during PrEP follow-up, compared to 194 cases in the 2-year period prior to enrolment, giving an incidence rate ratio (IRR) of 1.56 (CI 95% 1.30-1.89). The testing frequency increased by 75% (IRR 1.69, CI 95% 1.60-1.90). For diagnoses of active syphilis, the increase was 108% (IRR 2.08. CI 95% 1.04-4.06), compared with a 5-year period preceding enrolment. The hazard ratio of time (days) until a first STI after PrEP initiation was 2.87 (CI 95% 1.72-4.80) for those having had a STI prior to PrEP initiation and 2.06 (CI 95% 1.03-4.13) for those reporting experience of group sex in the past year compared with those who had not. STI prior to PrEP initiation and group sex were associated with STI after initiation of PrEP, factors that could be considered if needing prioritizing the frequency of STI screening.

Indexed as

Pre-Exposure ProphylaxisSexually Transmitted DiseasesAdultChlamydia InfectionsCohort StudiesGonorrheaHIV InfectionsHomosexuality, MaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedRetrospective StudiesSurveys and QuestionnairesSweden

Identifiers

PMID40187742
PMCPMC12311361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.